Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Ubiquinol-induced gene expression signatures are translated into altered parameters of erythropoiesis and reduced low density lipoprotein cholesterol levels in humans.

Schmelzer C, Niklowitz P, Okun JG, Haas D, Menke T, Döring F.

IUBMB Life. 2011 Jan;63(1):42-8. doi: 10.1002/iub.413.

2.

Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-alpha gene expression signature in SAMP1 mice.

Schmelzer C, Kubo H, Mori M, Sawashita J, Kitano M, Hosoe K, Boomgaarden I, Döring F, Higuchi K.

Mol Nutr Food Res. 2010 Jun;54(6):805-15. doi: 10.1002/mnfr.200900155.

PMID:
19960455
3.

The reduced form of coenzyme Q10 mediates distinct effects on cholesterol metabolism at the transcriptional and metabolite level in SAMP1 mice.

Schmelzer C, Okun JG, Haas D, Higuchi K, Sawashita J, Mori M, Döring F.

IUBMB Life. 2010 Nov;62(11):812-8. doi: 10.1002/iub.388.

4.

Coenzyme Q(10) supplementation inhibits aortic lipid oxidation but fails to attenuate intimal thickening in balloon-injured New Zealand white rabbits.

Choy KJ, Deng YM, Hou JY, Wu B, Lau A, Witting PK, Stocker R.

Free Radic Biol Med. 2003 Aug 1;35(3):300-9.

PMID:
12885592
6.

The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.

Jensen HK.

Dan Med Bull. 2002 Nov;49(4):318-45. Review.

PMID:
12553167
7.

Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients.

Cadoni G, Scipione S, Agostino S, Addolorato G, Cianfrone F, Leggio L, Paludetti G, Lippa S.

Otol Neurotol. 2007 Oct;28(7):878-83.

PMID:
17558340
8.
10.

Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice.

Thomas SR, Leichtweis SB, Pettersson K, Croft KD, Mori TA, Brown AJ, Stocker R.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):585-93.

11.

Ubiquinol-10 and total peroxyl radical trapping capacity of LDL lipoproteins during aging: the effects of Q-10 supplementation.

Aejmelaeus R, Metsä-Ketelä T, Laippala P, Solakivi T, Alho H.

Mol Aspects Med. 1997;18 Suppl:S113-20.

PMID:
9266512
12.
14.

Silencing of mouse hepatic lanosterol 14-alpha demethylase down-regulated plasma low-density lipoprotein cholesterol levels by short-term treatment of siRNA.

Xu B, Wang C, Yang J, Mao G, Zhang C, Liu D, Tai P, Zhou B, Xia G, Zhang M.

Biol Pharm Bull. 2008 Jun;31(6):1182-91.

15.

Coenzyme Q10: an independent predictor of mortality in chronic heart failure.

Molyneux SL, Florkowski CM, George PM, Pilbrow AP, Frampton CM, Lever M, Richards AM.

J Am Coll Cardiol. 2008 Oct 28;52(18):1435-41. doi: 10.1016/j.jacc.2008.07.044.

16.

Effects of fenofibrate therapy on plasma ubiquinol-10 and ubiquinone-10 levels in Japanese patients with hyperlipidemia and type 2 diabetes mellitus.

Asano A, Kobayashi J, Murase Y, Nohara A, Kawashiri MA, Inazu A, Shimizu M, Mabuchi H.

Pharmacotherapy. 2006 Apr;26(4):447-51.

PMID:
16553501
17.

Subchronic oral toxicity of ubiquinol in rats and dogs.

Kitano M, Watanabe D, Oda S, Kubo H, Kishida H, Fujii K, Kitahara M, Hosoe K.

Int J Toxicol. 2008 Mar-Apr;27(2):189-215. doi: 10.1080/10915810801978060.

PMID:
18404543
18.
19.
20.

Coenzyme Q10 changes are associated with metabolic syndrome.

Miles MV, Morrison JA, Horn PS, Tang PH, Pesce AJ.

Clin Chim Acta. 2004 Jun;344(1-2):173-9.

PMID:
15149886

Supplemental Content

Support Center